Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Osteoporosis
ADR ID BADD_A03222
ADR Hierarchy
14      Metabolism and nutrition disorders
14.04      Bone, calcium, magnesium and phosphorus metabolism disorders
14.04.04      Bone metabolism disorders
14.04.04.002      Osteoporosis
15      Musculoskeletal and connective tissue disorders
15.02      Bone disorders (excl congenital and fractures)
15.02.03      Metabolic bone disorders
15.02.03.002      Osteoporosis
Description A disorder characterized by reduced bone mass, with a decrease in cortical thickness and in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. [CTCAE] Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. [MeSH]
MedDRA Code 10031282
MeSH ID D010024
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Bone fragile | Disuse osteoporosis | Idiopathic osteoporosis | Osteoporosis | Osteoporosis NOS | Osteoporosis steroid-induced | Osteoporosis, unspecified | Other osteoporosis | Osteoporomalacia | Diffuse osteoporosis | Osteoporoses | Osteoporosis, Post-Traumatic | Osteoporosis, Post Traumatic | Post-Traumatic Osteoporoses | Post-Traumatic Osteoporosis | Osteoporosis, Senile | Osteoporoses, Senile | Senile Osteoporoses | Osteoporosis, Involutional | Senile Osteoporosis | Osteoporosis, Age-Related | Osteoporosis, Age Related | Bone Loss, Age-Related | Age-Related Bone Loss | Age-Related Bone Losses | Bone Loss, Age Related | Bone Losses, Age-Related | Age-Related Osteoporosis | Age Related Osteoporosis | Age-Related Osteoporoses | Osteoporoses, Age-Related
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02273Triamcinolone diacetate--
BADD_D02274Triamcinolone hexacetonide--
BADD_D02325Valdecoxib--
BADD_D02329Valproic acid--
BADD_D02331Valsartan0.000185%
BADD_D02337Varenicline--
BADD_D02338Varenicline tartrate--
BADD_D02346Venlafaxine0.000048%
BADD_D02369Voriconazole--
BADD_D02379Zaleplon--
BADD_D02392Zoledronic acid0.033782%
BADD_D02393Zolmitriptan--
BADD_D02407Upadacitinib0.001302%
BADD_D02412Octreotide--
BADD_D02436Atorvastatin--
BADD_D02443Tiotropium0.000230%
BADD_D02470Nintedanib--
BADD_D02473Sodium chloride--
BADD_D02492Deflazacort0.000511%
BADD_D02511Siponimod0.000530%
BADD_D02539Calcium0.000587%
The 6th Page    First    Pre   6    Total 6 Pages
ADReCS-Target
ADR Term Drug Name Target